POTASSIUM CHLORIDE IN SODIUM CHLORIDE INJECTION USP SOLUTION

Pays: Canada

Langue: anglais

Source: Health Canada

Ingrédients actifs:

SODIUM CHLORIDE; POTASSIUM CHLORIDE

Disponible depuis:

BAXTER CORPORATION

Code ATC:

B05BB01

DCI (Dénomination commune internationale):

ELECTROLYTES

Dosage:

450MG; 150MG

forme pharmaceutique:

SOLUTION

Composition:

SODIUM CHLORIDE 450MG; POTASSIUM CHLORIDE 150MG

Mode d'administration:

INTRAVENOUS

Unités en paquet:

1000ML

Type d'ordonnance:

Ethical

Domaine thérapeutique:

REPLACEMENT PREPARATIONS

Descriptif du produit:

Active ingredient group (AIG) number: 0213340004; AHFS:

Statut de autorisation:

MARKETED

Date de l'autorisation:

2008-03-31

Résumé des caractéristiques du produit

Potassium Chloride in 0.45% Sodium Chloride Injection, USP Prescribing
Information
_ _
_Page 1 of 14_
PRESCRIBING INFORMATION
POTASSIUM CHLORIDE IN 0.45% SODIUM CHLORIDE INJECTION, USP
IN PLASTIC CONTAINER
VIAFLEX
Container
20 mmol/L Potassium Chloride in 0.45% Sodium Chloride Injection
SOLUTION FOR INFUSION
Solutions Affecting the Electrolyte Balance
BAXTER CORPORATION
Mississauga, ON L5N 0C2
Date of Revision:
December 10, 2018
Control No. 221539
Potassium Chloride in 0.45% Sodium Chloride Injection, USP Prescribing
Information
_ _
_Page 2 of 14_
TABLE OF CONTENTS
SUMMARY PRODUCT INFORMATION
....................................................................................3
INDICATIONS AND CLINICAL USE
..........................................................................................3
CONTRAINDICATIONS
...............................................................................................................3
WARNINGS AND PRECAUTIONS
..............................................................................................3
SPECIAL POPULATIONS
.............................................................................................................7
ADVERSE REACTIONS
................................................................................................................8
DRUG INTERACTIONS
................................................................................................................8
DOSAGE AND ADMINISTRATION
............................................................................................9
INSTRUCTIONS FOR USE AND HANDLING AND DISPOSAL
............................................10
DIRECTIONS FOR USE OF VIAFLEX PLUS PLASTIC CONTAINER
..................................11
OVERDOSE
..................................................................................................................................12
ACTION AND CLINICAL PHARMACOLOGY
........................................................................13
STORAGE AND STABILITY
..................